# IQVIA (IQV) — Earnings

IQV · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/iqv/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $3.15 |
| EPS estimate | $3.03 |
| EPS surprise | +3.89% |
| Revenue surprise | +1.53% |
| Revenue | $4.4B |
| Revenue estimate | $4.3B |
| Reported | Jul 28, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1478242/000162828026050211/iqv-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/24cb1ca0-c36d-2aff-19d2-1cb09370c422.html) |

IQVIA reported Q2 2026 results on July 28, 2026. Earnings per share came in at $3.15, ahead of the $3.03 estimate by 3.89%. Revenue was $4.4 billion, above the $4.3 billion consensus. Compared with Q2 2025, EPS rose about 12.1% from $2.81 and revenue rose 10% from $4.0 billion.

The longer record shows steady growth. Annual EPS was $10.17 in 2022 and $10.21 in 2023, then rose to $11.14 in 2024 and $11.93 in 2025, about 17.3% above the 2022 level. Revenue climbed from $14.4 billion in 2022 to $16.3 billion in 2025. The first half of 2026 adds up to $6.05 per share, about 9.8% more than the same period a year earlier. Q4 is usually the strongest quarter, and Q4 2025 set the EPS high in the table at $3.42. Q2 2026 revenue matched the table's high of $4.4 billion. IQVIA topped the EPS estimate in all of the last 20 quarters, by margins between 0.35% and 4.74%.

IQVIA reported Q3 between October 21 and November 1 in each of the past five years. That points to late October 2026 for the next report. It will show whether recent year-over-year growth carries into the second half.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 28, 2026 | $3.03 | $3.15 | 3.89% | $4.3B | $4.4B |
| Q1 2026 | May 5, 2026 | $2.82 | $2.90 | 2.96% | $4.1B | $4.2B |
| Q4 2025 | Feb 5, 2026 | $3.39 | $3.42 | 0.81% | $4.2B | $4.4B |
| Q3 2025 | Oct 28, 2025 | $2.98 | $3.00 | 0.59% | $4.1B | $4.1B |
| Q2 2025 | Jul 22, 2025 | $2.77 | $2.81 | 1.42% | $4.0B | $4.0B |
| Q1 2025 | May 6, 2025 | $2.63 | $2.70 | 2.54% | $3.8B | $3.8B |
| Q4 2024 | Feb 6, 2025 | $3.11 | $3.12 | 0.35% | $3.9B | $4.0B |
| Q3 2024 | Oct 31, 2024 | $2.82 | $2.84 | 0.56% | $3.9B | $3.9B |
| Q2 2024 | Jul 22, 2024 | $2.56 | $2.64 | 2.94% | $3.8B | $3.8B |
| Q1 2024 | May 2, 2024 | $2.49 | $2.54 | 2.09% | $3.7B | $3.7B |
| Q4 2023 | Feb 14, 2024 | $2.82 | $2.84 | 0.66% | $3.8B | $3.9B |
| Q3 2023 | Nov 1, 2023 | $2.44 | $2.49 | 1.89% | $3.8B | $3.7B |
| Q2 2023 | Aug 1, 2023 | $2.38 | $2.43 | 1.90% | $3.7B | $3.7B |
| Q1 2023 | Apr 27, 2023 | $2.41 | $2.45 | 1.73% | $3.6B | $3.7B |
| Q4 2022 | Feb 10, 2023 | $2.76 | $2.78 | 0.60% | $3.7B | $3.7B |
| Q3 2022 | Oct 26, 2022 | $2.39 | $2.48 | 3.74% | $3.5B | $3.6B |
| Q2 2022 | Jul 21, 2022 | $2.38 | $2.44 | 2.35% | $3.5B | $3.5B |
| Q1 2022 | Apr 27, 2022 | $2.42 | $2.47 | 2.01% | $3.5B | $3.6B |
| Q4 2021 | Feb 15, 2022 | $2.43 | $2.55 | 4.74% | $3.6B | $3.6B |
| Q3 2021 | Oct 21, 2021 | $2.12 | $2.17 | 2.22% | $3.3B | $3.4B |

## Frequently Asked Questions

### When did IQVIA (IQV) last report earnings?

IQVIA last reported on Jul 28, 2026, covering fiscal Q2 2026.

### Did IQV beat earnings estimates?

Yes. IQVIA reported EPS of $3.15 for Q2 2026 against a $3.03 estimate — a 3.89% beat.

### How much revenue did IQV report last quarter?

IQVIA reported $4.4B in revenue for Q2 2026, against a consensus estimate of $4.3B.

## Similar Stocks

- [CRL](https://www.lighthorse.io/tickers/crl) — Charles River Laboratories International, Inc. Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [ICLR](https://www.lighthorse.io/tickers/iclr) — ICON plc - Ordinary Shares
- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock
- [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock
- [MTD](https://www.lighthorse.io/tickers/mtd) — Mettler-Toledo International, Inc. Common Stock
- [TECH](https://www.lighthorse.io/tickers/tech) — Bio-Techne Corp - Common Stock
- [WAT](https://www.lighthorse.io/tickers/wat) — Waters Corporation Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).